Frontlight ResearchEarly access
Atrial fibrillation trials in United States
147 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleClinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Where
- Columbus, Evanston, New York, Overland Park
- Age
- 21 years and over
- People
- 400
- Run by
- Volta Medical
See details and how to joinNCT06056271 - No phaseTaking peopleCOMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation
- Where
- Stanford
- Age
- 21 years to 90 years
- People
- 1,000
- Run by
- Stanford University
See details and how to joinNCT02997254 - No phaseTaking peopleMachine Learning in Atrial Fibrillation
- Where
- Stanford
- Age
- 22 years to 80 years
- People
- 120
- Run by
- Stanford University
See details and how to joinNCT05371405 - Phase 3Taking peopleSemaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- Where
- Chicago, Phoenix
- Age
- 18 years to 75 years
- People
- 200
- Run by
- University of Chicago
See details and how to joinNCT06499857 - No phaseTaking peopleThe Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Where
- Atlanta, Aurora, Birmingham, Boston, Cincinnati, Janesville, Lansing, Louisville, Lynchburg, Mobile, Naples, Philadelphia, Pittsburgh, Puyallup, Richmond, Sarasota, Tacoma, Ventura, Winchester, Ypsilanti
- Age
- 18 years and over
- People
- 250
- Run by
- Heart Rhythm Clinical and Research Solutions, LLC
See details and how to joinNCT06324201 - No phaseTaking peopleEsophageal Temperature During PVI Using Q-DOT Micro
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 30
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT06392932 - No phaseTaking peopleImplanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
- Where
- New Hyde Park
- Age
- 18 years and over
- People
- 50
- Run by
- Northwell Health
See details and how to joinNCT05643235 - No phaseNot yet taking people in United StatesImpact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
- Where
- Independence, Kansas City, Overland Park
- Age
- 18 years and over
- People
- 300
- Run by
- Kansas City Heart Rhythm Research Foundation
See details and how to joinNCT05464511 - No phaseTaking peopleLong-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
- Where
- Overland Park
- Age
- 18 years and over
- People
- 100
- Run by
- Kansas City Heart Rhythm Research Foundation
See details and how to joinNCT06075628 - No phaseNot yet taking people in United StatesAssessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
- Where
- Independence, Kansas City, Overland Park
- Age
- 18 years and over
- People
- 100
- Run by
- Kansas City Heart Rhythm Research Foundation
See details and how to joinNCT06783868 - Phase 4Taking peoplePharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- Where
- Chicago, Oak Lawn
- Age
- 18 years to 100 years
- People
- 162
- Run by
- University of Illinois Chicago
See details and how to joinNCT02347111 - No phaseNot yet taking people in United StatesPerioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- Where
- Boston, Detroit, Evanston, Hartford, New York, Philadelphia
- Age
- 18 years and over
- People
- 920 worldwide
- Run by
- McMaster University
See details and how to joinNCT06957366 - No phaseTaking peopleGet With the Guidelines Atrial Fibrillation Registry
- Where
- Dallas
- Age
- 18 years to 125 years
- People
- 17,198
- Run by
- American Heart Association
See details and how to joinNCT06245187 - No phaseEnrolling by invitationCOR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- Where
- Melbourne
- Age
- 18 years and over
- People
- 15,000
- Run by
- Peerbridge Health, Inc
See details and how to joinNCT06763549 - Phase 1/2Taking peopleAmiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
- Where
- Louisville
- Age
- 20 years to 85 years
- People
- 80
- Run by
- Helios Cardio Inc.
See details and how to joinNCT06730828 - No phaseTaking peopleIdentification of Genomic Predictors of Adverse Events After Cardiac Surgery
- Where
- Boston, Dallas, Houston
- Age
- 20 years to 90 years
- People
- 4,000
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT01258231 - No phaseTaking peopleCardioFocus HeartLight Post-Approval Study
- Where
- Charlottesville, Chicago, New York, Tucson
- Age
- 18 years and over
- People
- 250
- Run by
- CardioFocus
See details and how to joinNCT03168659 - No phaseTaking peopleLow Voltage-Directed Catheter Ablation for Atrial Fibrillation
- Where
- Cleveland
- Age
- 18 years to 85 years
- People
- 250
- Run by
- Ohad Ziv
See details and how to joinNCT03355456 - No phaseTaking peopleMANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
- Where
- Chicago
- Age
- 18 years and over
- People
- 1,000
- Run by
- CorVita Science Foundation
See details and how to joinNCT05978466 - Phase 2Taking peopleRiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 78
- Run by
- University of Utah
See details and how to joinNCT05292209 - No phaseTaking peopleCardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
- Where
- Glenwood Springs
- Age
- 18 years and over
- People
- 1,000
- Run by
- Cardiovascular Innovation and Research Institute
See details and how to joinNCT03428048 - Phase 2Taking peopleChloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
- Where
- Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- University of South Florida
See details and how to joinNCT02932007